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Abstract
Rothia spp. are gram-positive pleomorphic bacteria that are part of the normal oral microﬂora. They are associated with dental and
periodontal disease, although systemic infections have also been reported. We describe the case of a 75-year-old lady with rheumatoid
arthritis who presented with prosthetic knee joint infection due to Rothia aeria. We discuss its identiﬁcation and the evidence regarding
association of dental disease with Rothia spp. joint infections based on available literature.
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Introduction
Rothia spp. are gram-positive pleomorphic bacteria that are
part of the normal oral microﬂora. They are associated with
dental and periodontal disease [1,2]. The ﬁrst description of
disease in humans due to Rothia species was reported in 1975
in a case of peri-appendiceal abscess [3].
More recently a number of case reports have described
Rothia species as causing native and prosthetic endocarditis
[4,5] and other rare infections, including endophthalmitis [6,7],
corneal infections [8], peritoneal infections [9] and sepsis in an
immunocompromised patient [10] and a neonate [11].
Case Report
A 75-year-old lady with a history of seronegative erosive
rheumatoid arthritis since 1972 presented with painful swelling
of the right knee. She had bilateral knee replacements. The
right knee replacement was carried out in 1993 and the left
one in 2003. Her other co-morbidities included asthma,
arterial hypertension and chronic kidney disease. She was on
drug therapy for treatment for the above conditions and also
on methotrexate 12.5 mg once weekly and prednisolone
7.5 mg once a day, for more than 10 years. She had also
undergone multiple hand and wrist surgeries. She did not have
any history of trauma or previous knee infections.
On examination, body temperature was 38°C. Examination
showed swelling, erythema and tenderness of the knee and
upper calf. The initial blood tests showed white blood
cells = 25.7 9 109/L, neutrophils = 24.4 9 109/L, C-reactive
protein = 144 mg/L (normal <10 mg/L). Joint ﬂuid aspirate
contained 49 600 9 106 white blood cells/L with 90% neu-
trophils. Microscopy showed gram-positive bacilli and a culture
grew bacteria (Fig. 1). Identiﬁcation of this isolate was per-
formed by API Coryne (Biomerieux, Marcy l’Etoile, France). The
isolate was initially identiﬁed as Rothia dentocariosawith a proﬁle
of 7050121. This isolate was then sent to the Health Protection
Agency Regional reference laboratory in Colindale, London, UK
and was identiﬁed as Rothia aeria by 16S rRNA sequencing.
A two-stage revision procedure was undertaken. At the
ﬁrst stage, all the metallic prosthetic components were
extracted and spacers shaped like the prosthetic components
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(Biomet, Warsaw, IN, USA) were implanted. Vancomycin was
mixed into the cement. 2 g of vancomycin was used per 40 g
of cement. Four out of seven specimens grew R. aeria,
suggesting that this was a signiﬁcant organism. The patient
was treated with intravenous ceftriaxone (2 g once daily) for
approximately 2 weeks and then with teicoplanin (600 mg
once daily) for a further 4 weeks. Inﬂammatory markers
showed a steady decline during this period. The patient
underwent a re-implantation of the metallic prostheses
12 weeks following the ﬁrst stage of the revision procedure.
After 4 months following the revision the patient was doing
well with good functional joint and normal blood markers. A
subsequent review at the maxillofacial clinic at the hospital
identiﬁed some retained roots and dental caries that were
removed 5 months after surgery. Although the knee infection
was successfully treated, this patient unfortunately died of
Clostridium difﬁcile diarrhoea 6 months after the antibiotic
course.
Discussion
In 1967, Georg and Brown proposed the genus Rothia [12] for
a group of coccoid to diphtheroid to ﬁlamentous gram-positive
organisms isolated from the human oral cavity, naming the
genus after Roth [13], who had performed basic studies on
these organisms.
The taxonomic position of the genus Rothia has undergone a
number of changes since Georg and Brown ﬁrst assigned it to
the family Actinomycetaceae and proposed R. dentocariosa as
the type (and only) species [12]. Possible assignments to the
genera Actinomyces and Nocardia were rejected on chemotax-
onomic, metabolic and biochemical grounds. More recent
molecular studies placed the genus in the family Micrococc-
aceae, suborder Micrococcineae, order Actinomycetales, sub-
class Actinobacteridae, class Actinobacteria [14]. It is
therefore in the same family as the genera Micrococcus,
Arthrobacter, Kocuria, Nesterenkonia, Renibacterium and Stoma-
tococcus, all of which show characteristic signature nucleotides
in their 16S rDNA sequences [14]. Subsequently, Stomatococ-
cus mucilaginosus, the only species in the genus Stomatococcus,
was reclassiﬁed as Rothia mucilaginosa on the basis of 16S rRNA
gene sequence and whole-cell protein pattern [15]. Genomic
heterogeneity within R. dentocariosa has been observed [16].
Further, Rothia nasimurium, recovered from the nose of a
mouse [15], and Rothia amarae, recovered from sludge [17],
have been described and are both distinct phenotypically from
R. dentocariosa.
More recently, phylogenetic analysis of a gram-positive
bacterium strain A1-17BT isolated from Russian space station
air samples showed that it grouped with unofﬁcially named
R. dentocariosa genomovar II, [18]. As a result of a polyphasic
taxonomic study, the isolate was proposed to be classiﬁed as
the novel species Rothia aeria sp. nov. [18].
After an extensive literature search we have been able to
review six previously reported cases of Rothia joint infections
(Table 1).
It is evident from the above mentioned cases that signiﬁcant
rheumatological disease and orthopaedic surgeries are a
signiﬁcant risk factor for joint infections. Of the seven patients
studied, all but one [20] had dental disease. It is also interesting
that the two patients who had Rothia spp. joint infections
despite being immunocompetent had a history of dental
problems.
Of the seven Rothia spp. joint infections reported to date,
four were prosthetic joint infections and three were native
joint infections. In three of the four prosthetic joint infections
all the hardware was removed. In one of these cases [23]
hardware was removed only after treatment failure with
antibiotics and resection. In the fourth case [24], where
hardware was not removed, amoxicillin-clavulanate was con-
tinued indeﬁnitely.
To the best of our knowledge, our case is the ﬁrst report of
an R. aeria prosthetic joint infection. Rothia aeria has been
identiﬁed as a rare colonizing organism in the oral cavity of
healthy individuals [25].
Ko et al. [26] studied the identiﬁcation of Rothia isolates
from human patients and one of their conclusions was that two
strains which had previously been supposed to be R. dentoc-
ariosa according to the API Coryne system, were identiﬁed as
FIG. 1. Appearance of Rothia aeria on the culture plates.
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R. aeria by 16S rRNA gene analysis. Two other case reports
highlighted similar observations regarding the identiﬁcation of
Rothia spp. in their report [21,27]. This was also demonstrated
in our case. This would suggest that routine biochemical tests
may misidentify R. aeria as R. dentocariosa.
To date only six cases of systemic infections caused by
R. aeria have been reported (excluding the current case). In
these cases, R. aeria identiﬁcation was performed using the 16S
rRNA gene analysis [11,21,27–30].
Tarumoto et al. [28] reported the most recent case of
R. aeria invasive infection. The report described a case of
infective endocarditis in a 40-year-old Japanese man with a
history of smoking but no history of medical problems.
Unfortunately this case had a fatal outcome after cerebral
haemorrhagic infarction. The other reported cases of R. aeria
infection include a neck abscess in a patient with chronic
granulomatous disease [29], multifocal nodular pneumonia
[30], bronchitis [27], septic arthritis [21] and sepsis [11].
Falcone et al. [29] described the case of an R. aeria neck
abscess in a patient with chronic granulomatous disease. The
infection was aggressive, requiring two surgeries as well as
prolonged antibiotics for complete resolution. Matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) using a MALDI-TOF MicroFlex LT mass
spectrometer (Bruker Daltonics, Billerica, MA, USA) identiﬁed
it as Rothia species with best match to R. aeria. Full 16S rRNA
gene sequencing conﬁrmed the species level identiﬁcation with
a 99.8% match to the R. aeria type strain.
We took the opportunity to run the isolate from our case
(previously identiﬁed as R. aeria by 16S rRNA gene analysis)
through MALDI-TOF MS. The MALDI-TOF conﬁrmed the
isolate as Rothia spp. with best match to R. aeria.
Rothia aeria is susceptible to many antibiotics
[11,21,27,28,30]. However, it reportedly demonstrates inter-
mediate susceptibility to clindamycin and vancomycin [21,28].
Resistance to clindamycin [11,30], aztreonam [30] and oﬂox-
acin [27] has also been reported.
Conclusion
Rothia spp. joint infections are rare. Genetic identiﬁcation
down to the level of species is important because species of
Rothia can cause severe infections and certain species are not
susceptible to some antibiotics. Evidence suggests that 16S
rRNA sequencing or MALDI-TOF MS provide reliable
identiﬁcation of species. Failure of antibiotic treatment has
been reported in the absence of complete removal of
hardware.
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TABLE 1. Seven reported cases of Rothia genus joint infections (most recent ﬁrst)
First
author Organism
Age
(years) Joint
Dental
disease RA Immunosuppression Treatment Duration
Outcome
successful
Mahobia
et al.
Rothia aeria 75 Right
prosthetic
knee
Yes Yes Methotrexate,
prednisolone
Hardware removed,
IV ceftriaxone 2 g
once daily
2 weeks Yes
Teicoplanin 600 mg
once daily
4 weeks
Trivedi
et al. [19]
Rothia species
not known
53 Left
prosthetic
knee
Yes Yes No Hardware removed,
ertapenem 1 g daily +
amoxicillin-clavulanate
8 weeks Yes
Oral amoxicillin-clavulanate 4 months
Kaasch
et al. [20]
Rothia
mucilaginosa
73 Right native
knee
Unknown Yes Prednisolone Moxiﬂoxacin 400 mg
once daily
2 weeks Yes
Ampicillin plus sulbactam
375 mg twice daily
7 weeks
Verrall
et al. [21]
Rothia aeria 88 Both native
shoulders
Yes Yes Methotrexate,
prednisolone,
hydrocortisone
IV penicillin 2.4 g/day infusion 2 weeks Yes
Favero
et al. [22]
Rothia
dentocariosa
46 Right native
knee
Yes Yes Etanercept 25 mg
twice weekly,
oxaprozin
Levoﬂoxacin, clarithromycin Unknown Yes
Michels
et al. [23]
Rothia
mucilaginosa
59 Right
prosthetic
hip
Yes No No Hardware removed,
vancomycin
6 weeks Yes
Klingler
et al. [24]
Rothia
dentocariosa
44 Right
prosthetic
knee
Yes No
but
OA
Zidovudine,
lamivudine (HIV)
Patient declined hardware
removal, IV cefazolin
6 weeks Yes
Oral amoxicillin-clavulanate Indeﬁnitely
IV, intravenous; OA, osteoarthritis; RA, rheumatoid arthritis.
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